Clinical Trials in Michigan

Showing 11221-11240 of 16,154 trials

Measuring the Impact of MammaPrint on Adjuvant and Neoadjuvant Treatment in Breast Cancer Patients: A Prospective Registry

NCT02670577

The scope of this study is to measure the impact of MammaPrint on treatment in Hormone Receptor (HR)-positive HER2-negative breast cancer patients. In addition, the impact of MammaPrint on treatment in patients with T1a/T1b and pN0/pN1 (up to 1 node), Triple Negative or HER2-positive tumors will be assessed.

Breast Cancer

Agendia481 participantsStarted Nov 2015

Palm Springs, California, United States • Miami, Florida, United States • Tampa, Florida, United States +14 more locations

COMPLETEDPhase 283 miles

Temozolomide and Carmustine in Treating Patients With Anaplastic Glioma

NCT00003176

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of temozolomide and carmustine in treating patients with anaplastic glioma.

Brain and Central Nervous System Tumors

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins82 participantsStarted Mar 1998

Los Angeles, California, United States • San Francisco, California, United States • Boston, Massachusetts, United States +7 more locations

Measuring the Impact of MammaPrint on Adjuvant and Neoadjuvant Treatment in Breast Cancer Patients: A Prospective Registry

Temozolomide and Carmustine in Treating Patients With Anaplastic Glioma

Find Trials by Condition in Michigan

Rebif® Versus Copaxone® in the Treatment of Relapsing Remitting Multiple Sclerosis

Gefitinib in Treating Patients With Recurrent or Progressive CNS Tumors

Temozolomide Plus Thalidomide in Treating Patients With Recurrent or Progressive Brain Tumor

Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinoma

A Comparator Study of Fluticasone Propionate Nasal Spray Verses (vs) Cetirizine in the Treatment of Seasonal Allergic Rhinitis

Study to Assess the Immune Reactivity of the Liquid and Lyophilized Formulations of Palivizumab (MEDI-493, Synagis)

COOL-ARREST Pilot Study to Assess Intravascular Temperature Management (IVTM) in the Treatment of Cardiac Arrest

An Efficacy and Safety Study of Daratumumab in Patients With Multiple Myeloma Who Have Received at Least 3 Prior Lines of Therapy (Including a Proteasome Inhibitor [PI] and Immunomodulatory Drug [IMiD]) or Are Double Refractory to a PI and an IMiD

Innovative Tool to Increase Completion of Human Papillomavirus (HPV) Vaccine Series

VenaSeal Sapheon Closure System Pivotal Study (VeClose)

Safety and Tolerability Study of ISIS EIF4E Rx in Combination With Carboplatin and Paclitaxel

A Safety Study of Intravenous Pro-Netupitant and Palonosetron Combination for the Prevention of Nausea and Vomiting

A Study Evaluating the Safety and Pharmacokinetics of DMUC4064A in Participants With Platinum-Resistant Ovarian Cancer or Unresectable Pancreatic Cancer

Follow-up Study to Evaluate the Safety and Immunogenicity of a HPV Vaccine (580299) in North America

A Direct-to-patient Intervention to Increase Rates of Osteoporosis Care

Safety, Tolerability and Efficacy of ISIS-GCGRRx in Patients With Type 2 Diabetes

A Fixed Dose, Dose Response Study for Ropinirole Prolonged Release in Patients With Early Stage Parkinson's Disease

Sub-optimal Response to Anti-Tumor Necrosis Factor's in Inflammatory Bowel Disease in Emerging Markets